- Easing the pain
For thousands of Americans suffering from inoperable liver cancer, loss of hair, weakness, vomiting and thrush are common side effects they sadly encounter if they choose to undergo aggressive chemotherapy. However, a drug delivery company based in Stamford is looking to change the face of cancer treatment for specific organs ......
- Smart storage: Texas cancer center ensures continuous
treatment by using emerging storage networking technology. (Data
storage: case history).
Founded in 1974, San Antonio, Texas-based Cancer Therapy and Research Center (CTRC) is a world leader in cancer treatment and research. Since its founding, the not-for-profit center has handled nearly 1 million patient visits, and in 2002, more than 120,000 visits. The CTRC is also actively involved in the discovery ......
- Ovarian cancer treatment re-emerges after recent study
An ovarian cancer treatment protocol that had fallen out of favor over the past 20 years is re-emerging after a recent study found that the little-used method can extend a patient's life by more than a year.
- Natural born killers.
Cancer cells exist in all of our bodies. Thanks to the presence of Natural Killer (NK) cells that diligently patrol our system, these cells are prevented from mutating into dangerous cancerous growth. In light of this understanding, the world's cancer researchers have tried to increase the number of NK cells ......
- Gamma knife great advance in accuracy for radiation oncology
Cancer is one of the most feared words in the medical vocabulary but luckily the future for those with cancer is changing. According to Dr. Hans Baerwald, oncologist, Wyoming Valley Health Care System, "Even though the incidence of cancer continues to rise, the past 50 years have brought incredible advances ......
- AustCancer commences metastatic pancreatic cancer
study.
Australian Cancer Technology (Sydney, Australia), said it has initiated a Phase II clinical study of RP101 for the treatment of metastatic pancreatic cancer. The eight-month study, which will include 22 patients with metastatic pancreatic cancer, will be conducted at three leading centers in Germany: Chemnitz Clinics in collaboration with the ......
- EntreMed Research emphasizing low-dose cancer therapy
featured at cancer research meeting.
EntreMed, Inc. (Rockville, MD; 301-738-2490) announced that low-doses of Endostatin have the potential to significantly reduce cancer progression. A total of eleven scientific abstracts presented by EntreMed scientists and collaborators are featured at the 91st Annual Meeting of the American Association for Cancer Research in San Francisco. EntreMed's research is ......